Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

21.82
BATS BZX Real-Time Price
As of 12:37pm ET
 -0.31 / -1.40%
Today’s Change
12.51
Today|||52-Week Range
29.38
-17.10%
Year-to-Date
Worst-Performing Gurus' Stocks
May 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close22.13
Today’s open21.97
Day’s range21.80 - 22.11
Volume7,088
Average volume (3 months)234,598
Market cap$1.0B
Dividend yield--
Data as of 12:37pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-317.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.25%
P/E ratio53.3
Price/Sales12.75
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.22-3.18%
INSMInsmed Inc-0.15-0.86%
AIMTAimmune Therapeutics...-0.07-0.41%
FOLDAmicus Therapeutics ...+0.10+1.18%
Data as of 12:40pm ET, 05/25/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$87.5M
Annual profit (last year)$23.6M
Net profit margin26.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Secretary &
Vice President-Finance
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts